Effects of Tirapazamine on Human Tumors
Author Information
Author(s): E Lartigau, M Guichard
Primary Institution: Institut Gustave Roussy
Hypothesis
The study aims to define the toxicity and activity of tirapazamine alone and in combination with chemotherapy agents on xenografted human tumors.
Conclusion
Tirapazamine was shown to be cytotoxic against clonogenic human tumor cells, and its efficacy may depend on its combination with active chemotherapy drugs.
Supporting Evidence
- The combination of tirapazamine and bleomycin significantly increased the delay of regrowth compared with bleomycin alone.
- The combination of tirapazamine with VP16 significantly increased tumor doubling time compared with controls.
- Tirapazamine was more cytotoxic than VP16 alone.
Takeaway
Tirapazamine can help kill cancer cells when used with other drugs, but it can also make the treatment more dangerous for mice.
Methodology
The study used animal lethality, growth delay assays, and excision assays on nude mice with xenografted tumors.
Limitations
The study was conducted on mice, which may not fully represent human responses.
Participant Demographics
Nude mice bearing xenografted human tumors (rectal carcinoma and melanoma).
Statistical Information
P-Value
p=0.0001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website